CClinicalTrials.gg
CompletedNCT04921007Updated Jul 7, 2022

Ultrasound Guided Sacral Erector Spinae Plane Block in Pediatric Anorectal Surgery

An interventional study of Sacral ESP block and Caudal block in Analgesia, sponsored by Sameh Fathy. Completed at 1 site in Egypt. Open to participants aged 1 Year to 7 Years. Per ClinicalTrials.gov, last updated 2022-07-07.

Sponsored by Sameh Fathy · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Year to 7 Years
Sex
All
01

Study summary

This study will be conducted to evaluate efficacy of ultrasound guided sacral erector spinae plane block for postoperative analgesia in pediatric anorectal surgery in comparison to caudal block.

Read the detailed description

Regional anesthesia in children has become increasingly popular over the past few decades. A variety of peripheral and central nerve blocks have been developed to ensure that perioperative pain can be effectively controlled. So, it possible to reduce the dose concentrations of systemic drugs and improved hemodynamic stability in high-risk patients. Erector spinae plane (ESP) block with various approaches been used in many surgeries and obtained great popularity despite of its novelty. After first description; lower thoracic, lumbar and sacral approaches were defined for postoperative analgesia. There are a few cases in which sacral ESP block was administered and reported.

The aim of this study is to compare postoperative analgesic effect of ultrasound guided sacral ESP block and caudal block. It is hypothesized that sacral ESP block will be comparable to caudal block as a promising effective alternative for analgesia in patients who will undergo pediatric anorectal surgery with fewer side effects.

This prospective, randomized, comparative clinical study will include 60 children who will be scheduled for elective anorectal surgery under general anesthesia in Mansoura university hospitals. Informed written consent will be obtained from parents of all subjects in the study after ensuring confidentiality. The study protocol will be explained to parents of all patients in the study who will be kept fasting prior to surgery. Patients will be randomly assigned to two equal groups (ESP and caudal) according to computer-generated table of random numbers using the permuted block randomization method. The collected data will be coded, processed, and analyzed using SPSS program. All data will be considered statistically significant if P value is ≤ 0.05.

02

Conditions studied

  • Analgesia

Keywords

  • Erector spinae plane block
  • Ultrasound guided
  • Sacral
  • Anorectal surgery
03

In context

Lead sponsor

Sameh Fathy is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiology (ASA) I and II patients.
  • Scheduled for pediatric anorectal surgery

Exclusion criteria

Exclusion Criteria:

  • Parental refusal of consent.
  • Children with developmental delays, mental or neurological disorders.
  • Bleeding or coagulation diathesis.
  • History of known sensitivity to the used anesthetics.
  • Infection or redness at the injection site.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group (A) Sacral ESP block

    Ultrasound guided sacral erector spinae plane (ESP) block will be performed in the lateral position under sterile conditions, and bupivacaine will be administered.

    Procedure: Sacral ESP block · Drug: Bupivacaine Hydrochloride

  • Active comparator
    Group (B) Caudal block

    Ultrasound guided caudal block will be performed in the lateral position under sterile conditions, and bupivacaine will be administered.

    Procedure: Caudal block · Drug: Bupivacaine Hydrochloride

Interventions

  • ProcedureSacral ESP block

    A high-frequency ultrasound linear probe covered with a sterile sheath will be placed longitudinally to the midline of the sacrum. The median sacral crests and erector spinae muscle will be visualized, then a 22-gauge, 50 mm needle will be advanced from cranial to caudal direction until its tip touch the sacral crest.

    Also known as: Ultrasound guided approach

  • ProcedureCaudal block

    A high-frequency ultrasound linear probe covered with a sterile sheath will be placed on to the sacrococcygeal region. The dura mater, epidural space, conus medullaris, sacral cornua, and sacrococcygeal ligament will be identified. Using the in-plane technique, a 22-gauge, 50 mm needle will be introduced to reach the sacral epidural space.

    Also known as: Ultrasound guided approach

  • DrugBupivacaine Hydrochloride

    Following negative aspiration, a precalculated dose (0.5 ml/kg) of 0.25% bupivacaine will be injected.

    Also known as: Marcaine

06

What researchers measure

Primary outcomes

  1. Duration for the first analgesic request

    The time of the first analgesic request for paracetamol in minutes will be recorded.

    Time frame: Up to 24 hours after the procedure

Secondary outcomes

  1. Total analgesic requirements of paracetamol

    The amount of paracetamol consumption in milligrams given as a rescue analgesia

    Time frame: Up to 24 hours after the procedure

  2. Improvement in pain scores

    Pain score from 0 to 10 (0 = no pain and 10 = the worst imaginable pain) is assessed postoperatively at 1, 2, 4, 8, 12, 24 hours

    Time frame: Up to 24 hours after the procedure

  3. Changes in heart rate

    Heart rate (beat/min) is recorded at ten-minute intervals until the end of the surgery.

    Time frame: Up to end of the surgery

  4. Changes in mean arterial blood pressure

    Blood pressure (mmHg) is recorded at ten-minute intervals until the end of the surgery.

    Time frame: Up to end of the surgery

  5. Changes in postoperative emergence agitation scale

    Agitation is assessed using the 5- step Cravero scale (1-5) every five minutes from awakening and for 30 minutes.(1:Obtunded with no response to stimulation, 2:Asleep but responsive to movement or stimulation, 3:Awake and responsive, 4:Crying, 5:Thrashing behaviour that requires restraint)

    Time frame: Up to 30 minutes after the procedure

  6. Value of parent satisfaction from the procedure

    The parents will be investigated postoperatively for the quality of the procedure verbally (0-10; 0=None, 10=total satisfaction)

    Time frame: Up to 24 hours after the procedure

07

Study locations

1 site
  • Department of Anesthesia, Mansoura University Hospitals
    Mansoura, Dakahlia 35511, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04921007
Lead sponsor
Sameh Fathy
Responsible party
Sameh Fathy (Lecturer of anesthesia, ICU & pain management; Faculty of Medicine, Mansoura University) — Sponsor-investigator
First posted
Jun 10, 2021
Start date
Aug 13, 2021
Primary completion
Jul 1, 2022
Completion
Jul 1, 2022
Last update
Jul 7, 2022

Study contacts

Sameh M El-Sherbiny, MD
principal investigator · Mansoura Faculty of Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion